Time and deprivation trends in incidence of primary liver cancer subtypes in England

Journal of Evaluation in Clinical Practice

Volumn 20, Issue 4, 2014, Pages 498-504

  Konfortion, Julie ^a   Coupland, Victoria H ^a   Kocher, Hemant M ^b   Allum, William ^c   Grocock, Melanie J ^a   Jack, Ruth H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

hepatocellular carcinoma; incidence; intrahepatic cholangiocarcinoma; liver neoplasms; trends

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; COHORT ANALYSIS; FEMALE; HUMAN; ICD-10; ICD-9; ICD-O-2; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERNATIONAL CLASSIFICATION OF DISEASES FOR ONCOLOGY; LIVER CANCER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEX RATIO; SOCIO ECONOMIC DEPRIVATION QUINTILE; SOCIOECONOMICS; TIME; TREND STUDY; UNITED KINGDOM; BILE DUCT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CLASSIFICATION; FACTUAL DATABASE; INCIDENCE; INTRAHEPATIC BILE DUCT; LIVER NEOPLASMS; SOCIAL CLASS;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; DATABASES, FACTUAL; ENGLAND; FEMALE; HUMANS; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; LIVER NEOPLASMS; MALE; SOCIAL CLASS; TIME FACTORS;

EID: 84904041910     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/jep.12188     Document Type: Article

References (44)

1. Office for National Statistics (2013) Cancer Statistics Registrations, England, Series MB1 No. 42, 2011. London: Office for National Statistics.
2. International Agency on Cancer Research (2012) Globocan 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. Available at: http://globocan.iarc.fr/Default.aspx (last accessed 4 February 2014).
3. Bosch, F. X., Ribes, J., Diaz, M., &, Cleries, R., (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology, 127 (5), S5-S16.
4. Taylor-Robinson, S. D., Foster, G. R., Arora, S., Hargreaves, S., &, Thomas, H. C., (1997) Increase in primary liver cancer in the UK, 1979-94. Lancet, 350 (9085), 1142-1143.
5. McGlynn, K. A., Tsao, L., Hsing, A. W., Devesa, S. S., &, Fraumeni, J. F. Jr, (2001) International trends and patterns of primary liver cancer. International Journal of Cancer, 94 (2), 290-296.
6. Saracci, R., &, Repetto, F., (1980) Time trends of primary liver cancer: indication of increased incidence in selected cancer registry populations. Journal of the National Cancer Institute, 65 (2), 241-247.
7. West, J., Wood, H., Logan, R. F., Quinn, M., &, Aithal, G. P., (2006) Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. British Journal of Cancer, 94 (11), 1751-1758.
8. Srivatanakul, P., Sriplung, H., &, Deerasamee, S., (2004) Epidemiology of liver cancer: an overview. Asian Pacific Journal of Cancer Prevention, 5 (2), 118-125.
9. Parkin, D. M., Bray, F., Ferlay, J., &, Pisani, P., (2005) Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 55 (2), 74-108.
10. El-Serag, H. B., &, Rudolph, K. L., (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132 (7), 2557-2576.
11. Cabibbo, G., &, Craxi, A., (2010) Epidemiology, risk factors and surveillance of hepatocellular carcinoma. European Review for Medical and Pharmacological Sciences, 14 (4), 352-355.
12. Verhoef, C., Visser, O., de Man, R. A., de Wilt, J. H. W., Ijzermans, J. N. M., &, Janssen-Heijnen, M. L. G., (2004) Hepatocellular carcinoma in the Netherlands incidence, treatment and survival patterns. European Journal of Cancer, 40 (10), 1530-1538.
13. Witjes, C. D., Karim-Kos, H. E., Visser, O., van den Akker, S. A., de Vries, E., Ijzermans, J. N., de Man, R. A., Coebergh, J. W., &, Verhoef, C., (2012) Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival. European Journal of Gastroenterology and Hepatology, 24 (4), 450-457.
14. Altekruse, S. F., McGlynn, K. A., &, Reichman, M. E., (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. Journal of Clinical Oncology, 27 (9), 1485-1491.
15. von Hahn, T., Ciesek, S., Wegener, G., Plentz, R. R., Weismuller, T. J., Wedemeyer, H., Manns, M. P., Greten, T. F., &, Malek, N. P., (2011) Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany. Scandinavian Journal of Gastroenterology, 46 (9), 1092-1098.
16. Alvaro, D., Crocetti, E., Ferretti, S., Bragazzi, M. C., Capocaccia, R., &, Comm, A. C., (2010) Descriptive epidemiology of cholangiocarcinoma in Italy. Digestive and Liver Disease, 42 (7), 490-495.
17. Welzel, T. M., McGlynn, K. A., Hsing, A. W., O'Brien, T. R., &, Pfeiffer, R. M., (2006) Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. Journal of the National Cancer Institute, 98 (12), 873-875.
18. Wood, R., Brewster, D. H., Fraser, L. A., Brown, H., Hayes, P. C., &, Garden, O. J., (2003) Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland. European Journal of Cancer, 39 (14), 2087-2092.
19. Pocobelli, G., Cook, L. S., Brant, R., &, Lee, S. S., (2008) Hepatocellular carcinoma incidence trends in Canada: analysis by birth cohort and period of diagnosis. Liver International, 28 (9), 1272-1279.
20. Ahmed, F., Perz, J. F., Kwong, S., Jamison, P. M., Friedman, C., &, Bell, B. P., (2008) National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Preventing Chronic Disease, 5 (3), A74.
21. McGlynn, K. A., Tarone, R. E., &, El-Serag, H. B., (2006) A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiology, Biomarkers and Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 15 (6), 1198-1203.
22. Schutte, K., Bornschein, J., &, Malfertheiner, P., (2009) Hepatocellular carcinoma-epidemiological trends and risk factors. Digestive Diseases, 27 (2), 80-92.
23. Gomaa, A. I., Khan, S. A., Toledano, M. B., Waked, I., &, Taylor-Robinson, S. D., (2008) Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World Journal of Gastroenterology, 14 (27), 4300-4308.
24. Tyson, G. L., &, El-Serag, H. B., (2011) Risk factors for cholangiocarcinoma. Hepatology, 54 (1), 173-184.
25. Palmer, W. C., &, Patel, T., (2012) Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. Journal of Hepatology, 57 (1), 69-76.
26. National Cancer Intelligence Network (2008) Cancer incidence by deprivation England, 1995-2004. Available at: http://www.ncin.org.uk/ publications/reports/ (last accessed 16 May 2014).
27. Scotland ISD (2012) Incidence and mortality by deprivation category. Available at: http://www.isdscotland.org/Health-Topics/Cancer/Cancer-Statistics/ Liver/ (last accessed 16 May 2014).
28. Faggiano, F., Partanen, T., Kogevinas, M., &, Boffetta, P., (1997) Socioeconomic differences in cancer incidence and mortality. IARC Scientific Publications, 138, 65-176.
29. Weiderpass, E., &, Pukkala, E., (2006) Time trends in socioeconomic differences in incidence rates of cancers of gastro-intestinal tract in Finland. BMC Gastroenterology, 6, 41.
30. Department for Communities and Local Government (2012) English indices of deprivation. Available at: https://www.gov.uk/government/collections/english- indices-of-deprivation (last accessed 16 May 2014).
31. Bertuccio, P., Bosetti, C., Levi, F., Decarli, A., Negri, E., &, La Vecchia, C., (2013) A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe. Annals of Oncology, 24 (6), 1667-1674.
32. El-Serag, H. B., (2004) Hepatocellular carcinoma: recent trends in the United States. Gastroenterology, 127 (5 Suppl. 1), S27-S34.
33. Parkin, D. M., (2011) 3. Cancers attributable to consumption of alcohol in the UK in 2010. British Journal of Cancer, 105 (Suppl. 2), S14-S18.
34. Shebl, F. M., Capo-Ramos, D. E., Graubard, B. I., McGlynn, K. A., &, Altekruse, S. F., (2012) Socioeconomic status and hepatocellular carcinoma in the United States. Cancer Epidemiology, Biomarkers and Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 21 (8), 1330-1335.
35. Yun, E. H., Lim, M. K., Oh, J. K., Park, J. H., Shin, A., Sung, J., &, Park, E. C., (2010) Combined effect of socioeconomic status, viral hepatitis, and lifestyles on hepatocelluar carcinoma risk in Korea. British Journal of Cancer, 103 (5), 741-746.
36. Meffre, C., Le Strat, Y., Delarocque-Astagneau, E., et al. (2010) Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. Journal of Medical Virology, 82 (4), 546-555.
37. Ladep, N. G., Khan, S. A., Crossey, M. M., Thillainayagam, A. V., Taylor-Robinson, S. D., &, Toledano, M. B., (2014) Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations. World Journal of Gastroenterology, 20 (6), 1544-1553.
38. Jepsen, P., Vilstrup, H., Tarone, R. E., Friis, S., &, Sorensen, H. T., (2007) Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002. Journal of the National Cancer Institute, 99 (11), 895-897.
39. Lepage, C., Cottet, V., Chauvenet, M., Phelip, J. M., Bedenne, L., Faivre, J., &, Bouvier, A. M., (2011) Trends in the incidence and management of biliary tract cancer: a French population-based study. Journal of Hepatology, 54 (2), 306-310.
40. Patel, T., (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology, 33 (6), 1353-1357.
41. Taylor-Robinson, S. D., Toledano, M. B., Arora, S., Keegan, T. J., Hargreaves, S., Beck, A., Khan, S. A., Elliott, P., &, Thomas, H. C., (2001) Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut, 48 (6), 816-820.
42. Shaib, Y. H., Davila, J. A., McGlynn, K., &, El-Serag, H. B., (2004) Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? Journal of Hepatology, 40 (3), 472-477.
43. Khan, S. A., Emadossadaty, S., Ladep, N. G., Thomas, H. C., Elliott, P., Taylor-Robinson, S. D., &, Toledano, M. B., (2012) Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? Journal of Hepatology, 56 (4), 848-854.
44. Kumar, M., Zhao, X., &, Wang, X. W., (2011) Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? Cell & Bioscience, 1 (1), 5.